ATYR PHARMA, INC. (LIFE) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
On November 14, 2016, aTyr Pharma, Inc. (the Company) announced
financial results for the quarter ended September 30, 2016 in the
earnings release attached hereto as Exhibit 99.1.
The information under this Item 2.02, including Exhibit 99.1
hereto is being furnished and shall not be deemed filed for the
purposes of Section 18 of the Securities and Exchange Act of
1934, as amended (the Exchange Act), or otherwise subject to the
liabilities of that section, nor shall such information be deemed
incorporated by reference into any filing under the Securities
Act of 1933, as amended (the Securities Act) or the Exchange Act,
except as expressly set forth by specific reference in such
filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
99.1 |
Earnings Press Release of aTyr Pharma, Inc. dated |
About ATYR PHARMA, INC. (LIFE)
